Clinical Trial Update: The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating how an Enhanced Recovery After Surgery (ERAS) program affects clinical and immunological outcomes after minimally invasive gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Enhanced Recovery After Surgery for Laparoscopic Gastrectomy for Patients With Gastric Cancer | Phase 3 | Status: UNKNOWN